cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.16638985
title: ASINA Dataset: LC1_pchem (UNILI)

description: The dataset provides morphological, crystallographic, and surface chemistry data. Morphology is assessed via Transmission Electron Microscopy (TEM), with particle size distribution measured at multiple magnifications (50kX, 100kX, 400kX), including average sizes and SDs. Specific surface area and band gaps are also reported. Crystallographic properties are characterized using X-ray Diffraction (XRD) capturing crystallinity percentage, amorphous phase content, average crystallite size, and specific crystal structures. Surface chemistry is analyzed via X-ray Photoelectron Spectroscopy (XPS), providing elemental composition, binding energies for electron transitions, and % atomic concentration.
DOI: 10.5281/zenodo.16638986
title: ASINA Dataset: LC1_pchem (UNILI)

description: The dataset provides morphological, crystallographic, and surface chemistry data. Morphology is assessed via Transmission Electron Microscopy (TEM), with particle size distribution measured at multiple magnifications (50kX, 100kX, 400kX), including average sizes and SDs. Specific surface area and band gaps are also reported. Crystallographic properties are characterized using X-ray Diffraction (XRD) capturing crystallinity percentage, amorphous phase content, average crystallite size, and specific crystal structures. Surface chemistry is analyzed via X-ray Photoelectron Spectroscopy (XPS), providing elemental composition, binding energies for electron transitions, and % atomic concentration.
DOI: 10.15468/dl.uzwqjg
title: Occurrence Download

description: A dataset containing 40572 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (function (name, pos = -1, envir = as.environment(pos), all.names = FALSE, pattern, sorted = TRUE) \n{\n if (!missing(name)) {\n pos &lt;- tryCatch(name, error = function(e) e)\n if (inherits(pos, \"error\")) {\n name &lt;- substitute(name)\n if (!is.character(name)) \n name &lt;- deparse(name)\n warning(gettextf(\"%s converted to character string\", sQuote(name)), domain = NA)\n pos &lt;- name\n }\n }\n all.names &lt;- .Internal(ls(envir, all.names, sorted))\n if (!missing(pattern)) {\n if ((ll &lt;- length(grep(\"[\", pattern, fixed = TRUE))) && ll != length(grep(\"]\", pattern, fixed = TRUE))) {\n if (pattern == \"[\") {\n pattern &lt;- \"\\\\[\"\n warning(\"replaced regular expression pattern '[' by '\\\\\\\\['\")\n }\n else if (length(grep(\"[^\\\\\\\\]\\\\[&lt;-\", pattern))) {\n pattern &lt;- sub(\"\\\\[&lt;-\", \"\\\\\\\\\\\\[&lt;-\", pattern)\n warning(\"replaced '[&lt;-' by '\\\\\\\\[&lt;-' in regular expression pattern\")\n }\n }\n grep(pattern, all.names, value = TRUE)\n }\n else all.names\n}, Bidens pilosa, Ageratina adenophora, Chromolaena odorata, Praxelis clematidea, Leucaena leucocephala, Mimosa diplotricha, Trifolium repens, Oenothera biennis, Malvastrum coromandelianum, Amaranthus blitum, Amaranthus viridis, Opuntia dillenii, Solanum erianthum, Synedrella nodiflora, Sphagneticola trilobata, Tridax procumbens, Calopogonium mucunoides, Euphorbia hypericifolia, Euphorbia peplus, Phyllanthus amarus, Waltheria indica, Sieruela rutidosperma, Mitracarpus hirtus, Coreopsis lanceolata)",
 "BasisOfRecord is one of (Specimen, Human Observation, Observation, Living Specimen, Machine Observation, Literature Occurrence)",
 "Country is one of (China, Chinese Taipei)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 40572 records from 70 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007838-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.30185950
title: 原始data.zip

description: Data from instrument testing
DOI: 10.6084/m9.figshare.30185950.v1
title: 原始data.zip

description: Data from instrument testing
DOI: 10.6084/m9.figshare.29850099.v2
title: Perceived benefits and cost savings of liquid formulation of intravenous infliximab: perspectives of seven European countries

description: Following the approval of intravenous (IV) infliximab (IFX) in the 1990s, Celltrion developed the first monoclonal antibody biosimilar for IV IFX (Remsima®: Celltrion, South Korea), followed by the first and only subcutaneous IFX, (Remsima® SC). A liquid formulation of IV IFX has been developed that eliminates the need for reconstitution and introduces a 350 mg vial size not previously available with the powder formulation. This study evaluated the operational benefits and cost savings of the liquid formulation of IV IFX compared to the powder formulation, from the perspective of healthcare professionals across seven European countries. Semi-structured interviews were conducted with 21 hospital pharmacists and nurses involved in IV IFX preparation from May to June 2025. Interviewees noted that eliminating reconstitution reduced preparation time by 51% and resource costs by 20% per patient episode compared to the powder formulation, significantly alleviating healthcare professionals’ workload. The liquid formulation of IV IFX streamlines preparation, enhances operational efficiency, and reduces costs compared to the powder formulation. These savings allow resource reallocation to patient care, improving cost-effectiveness of IV IFX therapy. Its adoption is expected to optimize healthcare delivery across European healthcare systems.
DOI: 10.6084/m9.figshare.29712890.v1
title: Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysis

description: For moderate-to-severe psoriasis, clinical guidelines recommend biologic treatments after failure of at least one traditional systemic therapy. Biologics target different pathways, but a common challenge is loss of efficacy, often requiring a switch. This study explores real-world therapeutic management of moderate-to-severe psoriasis, focusing on biologic treatments. A retrospective study was conducted using health records of adult patients currently receiving biologics at Sant’Orsola Hospital in Bologna. Therapeutic sequences were investigated using state sequence analysis. Within-sequence Shannon entropy was calculated and used as the outcome in linear regression models. A directed acyclic graph informed the hierarchical regression models to identify factors influencing treatment duration. The cohort included 364 patients. Adalimumab was the most common first-line biologic (27%), followed by secukinumab (18%) and etanercept (16%). Nearly half of patients (48%) switched treatments. Increasing age was associated with lower sequence heterogeneity (β = -0.001, <i>p</i> = 0.002). Ustekinumab demonstrated the longest median treatment duration (1,841 days), while etanercept had the shortest (639 days). After adjusting for confounding variables, ustekinumab maintained its positive effect on treatment duration (β = 0.285, <i>p</i> = 0.009). The treatment duration for ustekinumab was encouraging, supporting its potential role as a durable option in these patients. Psoriasis is a long-lasting skin condition that can seriously affect people’s quality of life. When psoriasis is moderate-to-severe, doctors often prescribe medicines called biologics if other treatments, like traditional pills, stop working. Biologics work by blocking specific parts of the immune system that cause psoriasis. However, it is common for these medicines to lose their effect over time, meaning patients often need to switch to a different one.This study looked at how people with moderate-to-severe psoriasis are treated with biologics in real life. Researchers examined the medical records of 364 adults treated at Sant’Orsola Hospital in Bologna, Italy. They analyzed which biologic was used first, how often people switched treatments, and how long each medicine lasted before a switch was needed.The study found that almost half of the patients changed biologic at least once. Adalimumab was the most common first choice, but ustekinumab turned out to have the longest treatment duration. On average, patients stayed on ustekinumab for about 5 years, while etanercept had the shortest duration of about 2 years. Older patients tended to switch treatments less often.Overall, these findings suggest that ustekinumab may be a good long-term option for some people with psoriasis. Understanding how patients move from one treatment to another can help doctors make better choices and improve long-term care. More studies like this one can help ensure that people with psoriasis receive the best possible treatment for their needs
DOI: 10.6084/m9.figshare.29850099
title: Perceived benefits and cost savings of liquid formulation of intravenous infliximab: perspectives of seven European countries

description: Following the approval of intravenous (IV) infliximab (IFX) in the 1990s, Celltrion developed the first monoclonal antibody biosimilar for IV IFX (Remsima®: Celltrion, South Korea), followed by the first and only subcutaneous IFX, (Remsima® SC). A liquid formulation of IV IFX has been developed that eliminates the need for reconstitution and introduces a 350 mg vial size not previously available with the powder formulation. This study evaluated the operational benefits and cost savings of the liquid formulation of IV IFX compared to the powder formulation, from the perspective of healthcare professionals across seven European countries. Semi-structured interviews were conducted with 21 hospital pharmacists and nurses involved in IV IFX preparation from May to June 2025. Interviewees noted that eliminating reconstitution reduced preparation time by 51% and resource costs by 20% per patient episode compared to the powder formulation, significantly alleviating healthcare professionals’ workload. The liquid formulation of IV IFX streamlines preparation, enhances operational efficiency, and reduces costs compared to the powder formulation. These savings allow resource reallocation to patient care, improving cost-effectiveness of IV IFX therapy. Its adoption is expected to optimize healthcare delivery across European healthcare systems.
DOI: 10.6084/m9.figshare.29850099.v1
title: Perceived benefits and cost savings of liquid formulation of intravenous infliximab: perspectives of seven European countries

description: Following the approval of intravenous (IV) infliximab (IFX) in the 1990s, Celltrion developed the first monoclonal antibody biosimilar for IV IFX (Remsima®: Celltrion, South Korea), followed by the first and only subcutaneous IFX, (Remsima® SC). A liquid formulation of IV IFX has been developed that eliminates the need for reconstitution and introduces a 350 mg vial size not previously available with the powder formulation. This study evaluated the operational benefits and cost savings of the liquid formulation of IV IFX compared to the powder formulation, from the perspective of healthcare professionals across seven European countries. Semi-structured interviews were conducted with 21 hospital pharmacists and nurses involved in IV IFX preparation from May to June 2025. Interviewees noted that eliminating reconstitution reduced preparation time by 51% and resource costs by 20% per patient episode compared to the powder formulation, significantly alleviating healthcare professionals’ workload. The liquid formulation of IV IFX streamlines preparation, enhances operational efficiency, and reduces costs compared to the powder formulation. These savings allow resource reallocation to patient care, improving cost-effectiveness of IV IFX therapy. Its adoption is expected to optimize healthcare delivery across European healthcare systems.
DOI: 10.6084/m9.figshare.29868573
title: Evaluation of the drug-drug interaction between low-dose methotrexate and short-term use of non-steroidal anti-inflammatory drugs

description: There is ongoing debate about the clinical significance of the Drug–Drug Interaction (DDI) between low-dose methotrexate (LD-MTX) and the short-term use of non-steroidal anti-inflammatory drugs (NSAIDs), and clear guidance for DDI management is lacking. This review addresses this gap by providing a comprehensive overview of the current data on the DDI between LD-MTX and NSAIDs, to offer guidance on DDI management during short-term analgesic use. To explore the pharmacokinetic and pharmacodynamic aspects of the DDI between LD-MTX (≤30 mg weekly) and NSAIDs for short-term analgesic use (≤14 days), two literature searches were conducted in PubMed in May 2024. NSAIDs have minimal impact on MTX pharmacokinetics, with only minor increases in MTX clearance observed in two out of ten studies. Based on the available evidence, it seems unlikely that NSAIDs substantially increase the risk of adverse events when co-administered with LD-MTX, particularly when used short-term. In our opinion, no additional safety monitoring is required during short-term NSAID use in patients using LD-MTX in the absence of risk factors. In the presence of risk factors, i.e. renal insufficiency, dosage MTX &gt; 20 mg/week, diabetes mellitus, dehydration, and use of acetylsalicylic acid in analgesic dose, DDI management should be individualized.
DOI: 10.6084/m9.figshare.29868573.v1
title: Evaluation of the drug-drug interaction between low-dose methotrexate and short-term use of non-steroidal anti-inflammatory drugs

description: There is ongoing debate about the clinical significance of the Drug–Drug Interaction (DDI) between low-dose methotrexate (LD-MTX) and the short-term use of non-steroidal anti-inflammatory drugs (NSAIDs), and clear guidance for DDI management is lacking. This review addresses this gap by providing a comprehensive overview of the current data on the DDI between LD-MTX and NSAIDs, to offer guidance on DDI management during short-term analgesic use. To explore the pharmacokinetic and pharmacodynamic aspects of the DDI between LD-MTX (≤30 mg weekly) and NSAIDs for short-term analgesic use (≤14 days), two literature searches were conducted in PubMed in May 2024. NSAIDs have minimal impact on MTX pharmacokinetics, with only minor increases in MTX clearance observed in two out of ten studies. Based on the available evidence, it seems unlikely that NSAIDs substantially increase the risk of adverse events when co-administered with LD-MTX, particularly when used short-term. In our opinion, no additional safety monitoring is required during short-term NSAID use in patients using LD-MTX in the absence of risk factors. In the presence of risk factors, i.e. renal insufficiency, dosage MTX &gt; 20 mg/week, diabetes mellitus, dehydration, and use of acetylsalicylic acid in analgesic dose, DDI management should be individualized.
DOI: 10.6084/m9.figshare.26303137.v6
title: AMT measured points, width measured sections and areas within/SE to transition zone in the Loess Plateau

description: Locations of AMT measuring points to measure deposits in a river valley, locations of cross sections to constrain width of transition zone, locations to constrain areas of or southeast to transition zone.
DOI: 10.15468/dl.2nu477
title: Occurrence Download

description: A dataset containing 38 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Coincya rupestris)",
 "BasisOfRecord is one of (Specimen, Literature Occurrence, Human Observation, Observation)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 1991",
 "Year is less than or equal to 2025"
 ]
}

 The dataset includes 38 records from 8 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007844-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.hv7xsp
title: Occurrence Download

description: A dataset containing 1732 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Lavatera arborea",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present"
 ]
}

 The dataset includes 1732 records from 128 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007846-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.qkrmu3
title: Occurrence Download

description: A dataset containing 2501 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Eucalyptus grandis",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present"
 ]
}

 The dataset includes 2501 records from 58 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007845-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25345/c5tm72d7d
title: MassIVE MSV000099259 - Label free proteomics in M.smegmatis upon exposure to sub-inhibitory concentration of antibiotics_NOR_7p5hrs
title: Differential expression analysis of total proteome upon norfloxacin treatment at 7.5 hours in M.smegmatis
DOI: 10.15468/dl.qr9u7t
title: Occurrence Download

description: A dataset containing 2043 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is Stipa pennata",
 "Year is less than or equal to 2000",
 "Year is greater than or equal to 1970",
 {
 "or" : [
 {
 "not" : {
 "EstablishmentMeans" : [
 "is one of (MANAGED, INTRODUCED)"
 ]
 }
 },
 "EstablishmentMeans is null"
 ]
 },
 {
 "or" : [
 "CoordinateUncertaintyInMeters is less than 1000",
 "CoordinateUncertaintyInMeters is null"
 ]
 }
 ]
}

 The dataset includes 2043 records from 81 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007848-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.30185983
title: Quast assembly statistics and probiotic genes in the genome of <i>Megasphaera elsdenii</i> CH4

description: Genome assembly statistics of <i>Megasphaera elsdenii</i> CH4
DOI: 10.6084/m9.figshare.30185983.v1
title: Quast assembly statistics and probiotic genes in the genome of <i>Megasphaera elsdenii</i> CH4

description: Genome assembly statistics of <i>Megasphaera elsdenii</i> CH4
DOI: 10.15468/dl.xtnxwz
title: Occurrence Download

description: A dataset containing 194402 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Tanzania, United Republic of",
 "DatasetKey is Royal Botanic Gardens, Kew - Herbarium Specimens"
 ]
}

 The dataset includes 194402 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007827-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.nar9wb
title: Occurrence Download

description: A dataset containing 287 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Echinops bannaticus",
 "Country is Netherlands",
 "HasCoordinate is true"
 ]
}

 The dataset includes 287 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007849-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.nm23pk
title: Occurrence Download

description: A dataset containing 15 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Echinops bannaticus",
 "Country is Norway",
 "HasCoordinate is true"
 ]
}

 The dataset includes 15 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007850-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.uhrw4b
title: Occurrence Download

description: A dataset containing 50 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Centaurea gadorensis)",
 "BasisOfRecord is one of (Specimen, Literature Occurrence, Human Observation, Observation)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 1991",
 "Year is less than or equal to 2025"
 ]
}

 The dataset includes 50 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007852-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.wgbmmt
title: Occurrence Download

description: A dataset containing 547 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Echinops bannaticus",
 "Country is United Kingdom of Great Britain and Northern Ireland",
 "HasCoordinate is true"
 ]
}

 The dataset includes 547 records from 27 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007851-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.30001534
title: Quast assembly statistics and probiotic genes in the genome of <i>Megasphaera elsdenii</i> CH4

description: Genome assembly statistics of <i>Megasphaera elsdenii</i> CH4
DOI: 10.6084/m9.figshare.30001534.v4
title: Quast assembly statistics and probiotic genes in the genome of <i>Megasphaera elsdenii</i> CH4

description: Genome assembly statistics of <i>Megasphaera elsdenii</i> CH4
DOI: 10.6084/m9.figshare.30001534.v3
title: Quast assembly statistics of <i>Megasphaera elsdenii </i>CH4

description: Genome assembly statistics of <i>Megasphaera elsdenii</i> CH4
DOI: 10.15468/dl.2fkz3m
title: Occurrence Download

description: A dataset containing 212 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is Stipa pulchra",
 "Year is less than or equal to 2000",
 "Year is greater than or equal to 1970",
 {
 "or" : [
 {
 "not" : {
 "EstablishmentMeans" : [
 "is one of (MANAGED, INTRODUCED)"
 ]
 }
 },
 "EstablishmentMeans is null"
 ]
 },
 {
 "or" : [
 "CoordinateUncertaintyInMeters is less than 1000",
 "CoordinateUncertaintyInMeters is null"
 ]
 }
 ]
}

 The dataset includes 212 records from 25 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007853-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.uxwm8z
title: Occurrence Download

description: A dataset containing 57 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Gadoria falukei)",
 "BasisOfRecord is one of (Specimen, Literature Occurrence, Human Observation, Observation)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Year is greater than or equal to 1991",
 "Year is less than or equal to 2025"
 ]
}

 The dataset includes 57 records from 6 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007856-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.